GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Asset Turnover

Corix Bioscience (Corix Bioscience) Asset Turnover : 0.00 (As of Sep. 2017)


View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Corix Bioscience's Revenue for the three months ended in Sep. 2017 was $0.00 Mil. Corix Bioscience's Total Assets for the quarter that ended in Sep. 2017 was $7.40 Mil. Therefore, Corix Bioscience's Asset Turnover for the quarter that ended in Sep. 2017 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Corix Bioscience's annualized ROE % for the quarter that ended in Sep. 2017 was -249.88%. It is also linked to ROA % through Du Pont Formula. Corix Bioscience's annualized ROA % for the quarter that ended in Sep. 2017 was -169.72%.


Corix Bioscience Asset Turnover Historical Data

The historical data trend for Corix Bioscience's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Asset Turnover Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Asset Turnover
Get a 7-Day Free Trial - - - - 0.06

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Corix Bioscience's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corix Bioscience's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's Asset Turnover falls into.



Corix Bioscience Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Corix Bioscience's Asset Turnover for the fiscal year that ended in Dec. 2016 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2016 )/( (Total Assets (A: Jan. 2015 )+Total Assets (A: Dec. 2016 ))/ count )
=0.694/( (0+11.37)/ 1 )
=0.694/11.37
=0.06

Corix Bioscience's Asset Turnover for the quarter that ended in Sep. 2017 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2017 )/( (Total Assets (Q: Jun. 2017 )+Total Assets (Q: Sep. 2017 ))/ count )
=0/( (10.457+4.344)/ 2 )
=0/7.4005
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Corix Bioscience  (GREY:CXBS) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Corix Bioscience's annulized ROE % for the quarter that ended in Sep. 2017 is

ROE %**(Q: Sep. 2017 )
=Net Income/Total Stockholders Equity
=-12.56/5.0265
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-12.56 / 0)*(0 / 7.4005)*(7.4005/ 5.0265)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*1.4723
=ROA %*Equity Multiplier
=-169.72 %*1.4723
=-249.88 %

Note: The Net Income data used here is four times the quarterly (Sep. 2017) net income data. The Revenue data used here is four times the quarterly (Sep. 2017) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Corix Bioscience's annulized ROA % for the quarter that ended in Sep. 2017 is

ROA %(Q: Sep. 2017 )
=Net Income/Total Assets
=-12.56/7.4005
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-12.56 / 0)*(0 / 7.4005)
=Net Margin %*Asset Turnover
= %*0
=-169.72 %

Note: The Net Income data used here is four times the quarterly (Sep. 2017) net income data. The Revenue data used here is four times the quarterly (Sep. 2017) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Corix Bioscience Asset Turnover Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Corix Bioscience (Corix Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines